ING Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.31M Buy
37,991
+35,805
+1,638% +$7.83M 0.05% 187
2025
Q1
$489K Sell
2,186
-2,857
-57% -$640K ﹤0.01% 442
2024
Q4
$1.65M Sell
5,043
-1,169
-19% -$383K 0.01% 441
2024
Q3
$1.86M Sell
6,212
-19,390
-76% -$5.82M 0.01% 428
2024
Q2
$8.43M Buy
+25,602
New +$8.43M 0.05% 254
2024
Q1
Sell
-10,129
Closed -$3.57M 629
2023
Q4
$3.57M Buy
10,129
+556
+6% +$196K 0.03% 342
2023
Q3
$3.59M Sell
9,573
-1,033
-10% -$388K 0.03% 309
2023
Q2
$4.06M Buy
10,606
+9,926
+1,460% +$3.8M 0.03% 286
2023
Q1
$236K Sell
680
-11,907
-95% -$4.13M ﹤0.01% 515
2022
Q4
$2.96M Buy
12,587
+981
+8% +$231K 0.03% 306
2022
Q3
$2.86M Sell
11,606
-2,334
-17% -$574K 0.05% 235
2022
Q2
$4.22M Buy
13,940
+2,187
+19% +$661K 0.05% 271
2022
Q1
$4.83M Buy
11,753
+2,084
+22% +$856K 0.05% 255
2021
Q4
$4.54M Buy
9,669
+3,458
+56% +$1.62M 0.04% 294
2021
Q3
$2.64M Buy
6,211
+148
+2% +$62.8K 0.03% 298
2021
Q2
$2.18M Buy
6,063
+5,157
+569% +$1.85M 0.03% 296
2021
Q1
$255K Sell
906
-3,997
-82% -$1.12M 0.01% 501
2020
Q4
$1.39M Buy
4,903
+3,269
+200% +$926K 0.03% 313
2020
Q3
$449K Buy
+1,634
New +$449K 0.02% 319
2019
Q3
Sell
-11,264
Closed -$1.41M 768
2019
Q2
$1.41M Sell
11,264
-104
-0.9% -$13K 0.02% 322
2019
Q1
$1.25M Buy
11,368
+13
+0.1% +$1.43K 0.03% 281
2018
Q4
$1.11M Buy
11,355
+113
+1% +$11.1K 0.02% 314
2018
Q3
$1.39M Buy
+11,242
New +$1.39M 0.02% 305
2018
Q2
Sell
-11,254
Closed -$994K 861
2018
Q1
$994K Buy
11,254
+8,726
+345% +$771K 0.02% 329
2017
Q4
$249K Buy
+2,528
New +$249K ﹤0.01% 685
2017
Q3
Sell
-8,948
Closed -$846K 920
2017
Q2
$846K Buy
+8,948
New +$846K 0.02% 363